Correlation Between Cyxone AB and Mendus AB

Can any of the company-specific risk be diversified away by investing in both Cyxone AB and Mendus AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyxone AB and Mendus AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cyxone AB and Mendus AB, you can compare the effects of market volatilities on Cyxone AB and Mendus AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyxone AB with a short position of Mendus AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyxone AB and Mendus AB.

Diversification Opportunities for Cyxone AB and Mendus AB

0.0

Correlation Coefficient

Cyxone AB  Mendus AB

Pay attention - limited upside

The 3 months correlation between Cyxone and Mendus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cyxone AB and Mendus AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mendus AB and Cyxone AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyxone AB are associated (or correlated) with Mendus AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mendus AB has no effect on the direction of Cyxone AB i.e., Cyxone AB and Mendus AB go up and down completely randomly.

Pair Corralation between Cyxone AB and Mendus AB

If you would invest (100.00) in Cyxone AB on October 24, 2024 and sell it today you would earn a total of  100.00  from holding Cyxone AB or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Cyxone AB  vs.  Mendus AB

Cyxone AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cyxone AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyxone AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Mendus AB

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Mendus AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Cyxone AB and Mendus AB

The main advantage of trading using opposite Cyxone AB and Mendus AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyxone AB position performs unexpectedly, Mendus AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mendus AB will offset losses from the drop in Mendus AB's long position.

The idea behind Cyxone AB and Mendus AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.